Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.17 Insider Own16.11% Shs Outstand24.00M Perf Week7.48%
Market Cap2.20B Forward P/E17.57 EPS next Y5.20 Insider Trans-1.74% Shs Float20.25M Perf Month-7.10%
Income-28.04M PEG- EPS next Q1.22 Inst Own92.38% Short Float / Ratio6.29% / 3.90 Perf Quarter-36.95%
Sales2.25B P/S0.98 EPS this Y-2.06% Inst Trans-3.46% Short Interest1.27M Perf Half Y-50.48%
Book/sh86.93 P/B1.05 EPS next Y-18.81% ROA-0.64% Target Price130.00 Perf Year-42.64%
Cash/sh8.24 P/C11.08 EPS next 5Y16.00% ROE-1.36% 52W Range78.28 - 212.43 Perf YTD-42.00%
Dividend- P/FCF- EPS past 5Y- ROI-0.75% 52W High-57.00% Beta0.63
Dividend %- Quick Ratio0.98 Sales past 5Y15.12% Gross Margin31.82% 52W Low16.68% ATR4.14
Employees14500 Current Ratio2.62 Sales Q/Q-7.88% Oper. Margin2.29% RSI (14)49.18 Volatility4.95% 5.25%
OptionableYes Debt/Eq0.82 EPS Q/Q153.77% Profit Margin-1.25% Rel Volume1.47 Prev Close87.76
ShortableYes LT Debt/Eq0.79 EarningsNov 06 AMC Payout- Avg Volume326.77K Price91.34
Recom1.67 SMA204.43% SMA50-10.29% SMA200-39.72% Volume479,129 Change4.08%
Date Action Analyst Rating Change Price Target Change
Nov-08-22Downgrade Raymond James Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
Nov-27-23 06:28PM
Nov-07-23 10:36AM
Nov-06-23 11:37PM
04:05PM Loading…
Oct-27-23 09:06PM
Oct-23-23 08:30AM
Sep-25-23 08:40AM
Sep-12-23 01:01AM
Sep-05-23 08:30AM
Sep-04-23 09:34AM
Aug-29-23 08:00AM
Aug-09-23 07:01AM
Aug-08-23 07:36PM
06:31AM Loading…
Aug-07-23 08:13PM
Jul-24-23 08:30AM
Jun-21-23 08:00PM
Jun-20-23 05:13PM
May-10-23 06:09AM
May-09-23 05:25PM
May-08-23 05:35PM
Apr-26-23 08:00PM
07:56PM Loading…
Apr-24-23 07:56PM
Apr-11-23 07:07AM
Mar-29-23 09:47AM
Mar-15-23 05:55PM
Mar-09-23 08:30AM
Mar-02-23 05:44AM
Mar-01-23 07:11PM
Feb-28-23 11:05AM
Feb-27-23 06:15PM
Feb-26-23 08:04AM
Feb-21-23 08:30AM
Feb-13-23 08:30AM
Feb-08-23 08:00AM
Jan-23-23 08:55AM
Jan-20-23 07:21PM
Dec-19-22 08:30AM
Dec-03-22 07:28AM
Nov-07-22 06:35PM
Nov-06-22 07:21AM
Nov-01-22 09:00AM
Oct-31-22 04:01PM
Oct-07-22 10:08AM
Oct-06-22 08:30AM
Sep-26-22 08:18AM
Sep-08-22 08:30AM
Aug-09-22 03:15PM
Aug-08-22 06:15PM
Jul-19-22 08:30AM
Jun-18-22 08:51AM
May-19-22 08:05AM
May-11-22 04:12PM
May-09-22 05:45PM
May-06-22 03:18AM
May-05-22 02:52AM
May-04-22 03:05AM
Apr-20-22 08:30AM
Apr-19-22 07:51AM
Apr-14-22 02:37AM
Apr-13-22 06:54AM
Apr-12-22 02:31AM
Apr-11-22 05:04AM
Apr-08-22 02:37AM
Mar-24-22 08:03AM
Mar-23-22 12:00PM
Mar-22-22 12:45PM
Mar-14-22 08:30AM
Mar-10-22 12:48PM
Mar-05-22 08:42AM
Mar-04-22 09:40AM
Mar-03-22 12:45PM
Mar-02-22 08:30AM
Feb-24-22 06:20PM
Feb-17-22 03:02PM
Feb-07-22 02:29PM
Feb-04-22 08:30AM
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woolson DanielVP, GM-Infusion CapitalDec 01Sale88.031,729152,1969,877Dec 01 05:08 PM
Voigtlander Christian B.Chief Operating OfficerSep 08Sale129.046,850883,93013,603Sep 11 12:27 PM
Jain VivekChairman and CEOJul 12Option Exercise58.7930,0001,763,70053,677Jul 14 05:36 PM
Jain VivekChairman and CEOJul 12Sale180.0230,0005,400,72023,677Jul 14 05:36 PM
Jain VivekChairman and CEOJun 14Option Exercise58.7930,0001,763,70031,840Jun 15 10:22 AM
Jain VivekChairman and CEOJun 14Sale188.6730,0005,660,08623,677Jun 15 10:22 AM
FINNEY ELISHA WDirectorJun 07Sale190.4119436,9401,481Jun 07 04:26 PM
KENNEDY KOLLEEN TDirectorMay 17Option Exercise0.004850614May 18 12:51 PM
Hoffmeister David FDirectorMay 17Option Exercise0.0048502,079May 18 12:46 PM
FINNEY ELISHA WDirectorMay 17Option Exercise0.0048501,675May 18 12:41 PM
Abbey DonaldDirectorMay 17Option Exercise0.0048502,079May 18 12:37 PM
Hernandez LaurieDirectorMay 17Option Exercise0.004850937May 18 12:19 PM
Greenberg David C.DirectorMay 17Option Exercise0.0048504,089May 18 12:15 PM
Sanzone Virginia RuthVP, General CounselApr 11Sale175.0025043,7504,678Apr 11 02:11 PM
Sanzone Virginia RuthVP, General CounselApr 05Sale170.0045877,8604,928Apr 05 05:07 PM
Sanzone Virginia RuthVP, General CounselMar 08Option Exercise0.002,27206,582Mar 08 05:06 PM
Woolson DanielVP, GM-Infusion CapitalMar 08Option Exercise0.002,020012,500Mar 08 05:09 PM
Voigtlander Christian B.Chief Operating OfficerMar 08Option Exercise0.002,209021,616Mar 08 04:59 PM
Jain VivekChairman and CEOMar 08Option Exercise0.002,525025,091Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 08Option Exercise0.002,209013,578Mar 08 04:52 PM
Bonnell Brian MichaelChief Financial OfficerMar 07Option Exercise0.002,145012,498Mar 08 04:52 PM
Jain VivekChairman and CEOMar 07Option Exercise0.003,218024,260Mar 08 04:56 PM
Voigtlander Christian B.Chief Operating OfficerMar 07Option Exercise0.002,145020,536Mar 08 04:59 PM
Woolson DanielVP, GM-Infusion CapitalMar 07Option Exercise0.00965010,908Mar 08 05:09 PM
Sanzone Virginia RuthVP, General CounselMar 07Option Exercise0.001,07204,874Mar 08 05:06 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.001,59504,641Mar 08 05:06 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.001,417010,569Mar 08 05:09 PM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.0010,296022,260Mar 08 04:59 PM
Jain VivekChairman and CEOMar 06Option Exercise0.0011,767026,303Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.0010,296014,957Mar 08 04:52 PM
Woolson DanielVP, GM-Infusion CapitalFeb 02Sale200.001,731346,2009,152Feb 02 02:57 PM